# STOP Heart Disease in Breast Cancer Survivors Trial

> **NCT02674204** · PHASE2 · TERMINATED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer
- Heart Disease
- Cardiotoxicity
- Myocardial Dysfunction

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02674204
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-05
- **Primary completion:** 2018-05-25
- **Final completion:** 2018-05-25
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Closed due to low accrual
- **Last updated:** 2019-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674204, "STOP Heart Disease in Breast Cancer Survivors Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02674204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*